Marshall Schwartz to Animals
This is a "connection" page, showing publications Marshall Schwartz has written about Animals.
Connection Strength
0.343
-
Karmaker A, Costanzo CM, Schwartz MZ. Is OM-3 synergistic with GLP-2 in intestinal failure? J Surg Res. 2017 01; 207:7-12.
Score: 0.059
-
Katz MS, Thatch KA, Schwartz MZ. Chronology of the effect of massive small bowel resection and hepatocyte growth factor (HGF) on intestinal adaptation. J Surg Res. 2011 Dec; 171(2):399-403.
Score: 0.041
-
Katz MS, Thatch KA, Schwartz MZ. The effect of hepatocyte growth factor on gene transcription during intestinal adaptation. J Pediatr Surg. 2011 Feb; 46(2):357-65.
Score: 0.041
-
Katz MS, Thatch KA, Schwartz MZ. Dose variation of hepatocyte growth factor and its effects on an animal model of TPN-induced liver injury. J Surg Res. 2010 Oct; 163(2):294-8.
Score: 0.039
-
Timmapuri SJ, Otterburn DM, Arafat H, Schwartz MZ. Hepatocyte growth factor increases glucagon immunoreactivity in jejunal cells during intestinal adaptation. J Pediatr Surg. 2006 Jan; 41(1):150-4; discussion 150-4.
Score: 0.029
-
Otterburn DM, Arthur LG, Timmapuri SJ, McCahan SM, Schwartz MZ. Proteasome gene upregulation: a possible mechanism for intestinal adaptation. J Pediatr Surg. 2005 Feb; 40(2):377-80.
Score: 0.027
-
Pearson PY, Yu D, Schwartz MZ. Transfection of the sodium/glucose cotransporter into colon mucosa: a novel treatment for short bowel syndrome. J Pediatr Surg. 2002 Jul; 37(7):1076-80; discussion 1076-80.
Score: 0.022
-
Kuenzler KA, Pearson PY, Schwartz MZ. Hepatocyte growth factor pretreatment reduces apoptosis and mucosal damage after intestinal ischemia-reperfusion. J Pediatr Surg. 2002 Jul; 37(7):1093-7; discussion 1093-7.
Score: 0.022
-
Kuenzler KA, Pearson PY, Schwartz MZ. Interleukin-11 enhances intestinal absorptive function after ischemia-reperfusion injury. J Pediatr Surg. 2002 Mar; 37(3):457-9.
Score: 0.022
-
Weis VG, Deal AC, Mekkey G, Clouse C, Gaffley M, Whitaker E, Peeler CB, Weis JA, Schwartz MZ, Atala A. Human placental-derived stem cell therapy ameliorates experimental necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol. 2021 04 01; 320(4):G658-G674.
Score: 0.020
-
Thatch KA, Schwartz MZ, Yoo EY, Mendelson KG, Duke DS. Modulation of the inflammatory response and apoptosis using epidermal growth factor and hepatocyte growth factor in a liver injury model: a potential approach to the management and treatment of cholestatic liver disease. J Pediatr Surg. 2008 Dec; 43(12):2169-73.
Score: 0.009
-
Arthur GL, Schwartz MZ, Kuenzler KA, Birbe R. Glucagonlike peptide-2 analogue: a possible new approach in the management of inflammatory bowel disease. J Pediatr Surg. 2004 Mar; 39(3):448-52; discussion 448-52.
Score: 0.006
-
Alavi K, Schwartz MZ, Prasad R, O'connor D, Funanage V. Leptin: a new growth factor for the small intestine. J Pediatr Surg. 2002 Mar; 37(3):327-30.
Score: 0.005